Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide

Lupus

Volumn 21, Issue 10, 2012, Pages 1119-1123

  Jasmin, R ^a   Sockalingam, S ^a   Shahrizaila, N ^a   Cheah, T E ^a   Zain, A A ^a   Goh, K J ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

chronic inflammatory demyelinating polyneuropathy; immunosuppressive therapy; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; DISEASE SEVERITY; DRUG DOSE REDUCTION; ELECTROMYOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE BIOPSY; MALE; PRIORITY JOURNAL; SKIN DEFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; TREATMENT OUTCOME;

EID: 84865085181     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312440346     Document Type: Article

References (15)

1. Bertsias GK, Ioannidis JPA, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010 ; 69: 2075-2082
2. Omdal R, Henriksen OA, Mellgren SI, Husby G. Peripheral neuropathy in systemic lupus erythematosus. Neurology. 1991 ; 41 (6). 808-811
3. Omdal R, Mellgren SI, Husby G, Salvesan R, Henriksen PA, Torbergsen T. A controlled study of peripheral neuropathy in systemic lupus erythematosus. Acta Neurol Scand. 1993 ; 88 (1). 41-46
4. Omdal R, Løseth S, Torbergsen T, Koldingnes W, Husby G, Mellgren SI. Peripheral neuropathy in systemic lupus erythematosus-a longitudinal study. Acta Neurol Scand. 2001 ; 103: 386-391
5. Goh KJ, Wang CL, Leong S, Tan CT. Peripheral neuropathy in systemic lupus erythematosus-electrophysiological features in 50 consecutive patients. Neurol J Southeast Asia. 1996 ; 1: 47-51
6. Hsu TY, Wang SH, Kuo CF, Chiu TF, Chang YC. Acute inflammatory demyelinating polyneuropathy as the initial presentation of lupus. Am J Emerg Med. 2009 ; 27 (7). 900.e3-5
7. Vaidya S, Jasin HE, Logan J. Systemic lupus erythematosus and Guillain-Barré syndrome. J Clin Rheumatol. 1999 ; 5(6): 349-353
8. Yildiz AK, Balaban H, Senel S, Çevik S. Acute lumbosacral polyradiculoneuropathy heralding transformation to systemic lupus erythematosus in a patient with discoid lupus. Lupus. 2011 ; 20: 972-974
9. Rechtland E, Cornblath D, Stern B, Meyerhoff JO. Chronic demyelinating polyneuropathy in SLE. Neurology. 1984 ; 34: 1375-1377
10. Vina ER, Fang AJ, Wallace DJ, Weisman MH. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome. Semin Arthritis Rheum. 2005 ; 35 (3). 175-184
11. Zoilo MA, Eduardo B, Enrique F, del Rocio MV. Chronic inflammatory demyelinating polyradiculoneuropathy in a boy with systemic lupus erythematosus. Rheumatol Int. 2010 ; 30 (7). 965-968
12. Hantson P, Kevers L, Fabien N, Van Den Bergh P. Acute-onset chronic inflammatory demyelinating polyneuropathy with cranial nerve involvement, dysautonomia, respiratory failure, and autoantibodies. Muscle Nerve. 2010 ; 41 (3). 423-426
13. Wang F, Wang CL, Tan CT, Manivasagar M. Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus. 1997 ; 6: 248-253
14. Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. Eur J Neurol. 2010 ; 17(3): 356-363
15. Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis. 2005 ; 64 (4). 620-625